News & Announcements

Don't Miss Our 2019 Conference!

Plan now to join us at the 2019 State of Michigan HIV & STD Conference, Aug. 13-14 at the Renaissance Conference Center in Detroit.

Dozens of local, regional and national experts in HIV and STD care and prevention will convene for two days of educational programming, exhibits, and social and networking activities with an eye toward maximizing their knowledge and skills, sharing best practices, and identifying new collaborative opportunities.

To learn more about the 2019 conference, visit

Looking for more trainings and events? Check out our special Training & Events webpage.

HIV STD Law Updates

In 2018, the Michigan Department of Health and Human Services (MDHHS) worked with the Michigan Legislature, HIV advocates, and HIV service providers to amend the Public Health Code statutes related to HIV. Changes include updating the HIV disclosure law, increased perinatal HIV/STD/Hepatitis B testing for at-risk women, reduced requirements for HIV testing consent requirements, and modifying HIV reporting and partner service requirements. Through this work, the health code now reflects the advancements in HIV science and the evolution of our processes and practices.

To highlight the changes for all statutes, MDHHS has created a summary document to assist in understanding the updates and the way they may influence your work in testing and treating HIV and other STDs. MDHHS asks our partners to familiarize themselves with the changes and to share the information with colleagues and medical professionals to adopt these changes as rapidly as possible. 

April is STD Awareness Month

STD Awareness Month, observed each April, is an opportunity to raise awareness about what STDs are and how they impact
our lives; and understand why it’s important to prevent, test for, and treat STDs. The surge of STDs endangers the health of too
many in the United States (U.S.). According to the CDC, from 2013-2017: syphilis cases nearly doubled, gonorrhea cases increased by 67 percent, and chlamydia cases remained at record highs.

Given this data, STD Awareness Month is a timely reminder to continue to raise awareness about STDs, take action to mitigate the increase in STDs in the U.S., and reduce STD-related stigma, fear, and discrimination.

For additional resources to help promote STD Awareness, please visit the STD Awareness Toolkit available here.

Clinical Alerts

Chlamydia and Gonorrhea Expedited Partner Therapy (EPT): Michigan Public Act 525 of 2014 (MCL 333.5110) authorized the use of expedited partner therapy (EPT) for certain sexually transmitted diseases as designated by the state health department. In January 2015, the Michigan Department of Health and Human Services designated chlamydia and gonorrhea as diseases for which the use of EPT is appropriate.

Michigan HIV Consultation Program: The Michigan HIV Consultation Program is set up to answer questions from Michigan healthcare professionals regarding HIV disease management; HIV drug-drug interactions; HIV occupational and non-occupational post-exposure prophylaxis (PEP and nPEP); HIV pre-exposure prophylaxis (PrEP); and perinatal HIV treatment. Providers with urgent questions can use the 24-hour consultation line at 313-575-0332.

Tools You Can Use

New information sheets about Syringe Services Programs (SSP) are now available from our partners in Viral Hepatitis:

What's New Around the State

Detroit Public Health STD Clinic Open: The Detroit Public Health STD Clinic is open for testing and treatment. Medicaid and most other insurances are accepted. If you don't have insurance, the clinic offers STD and HIV testing and treatment at little or no cost, regardless of your ability to pay. The clinic offers medical advice, guidance, and new treatments like HIV PrEP. Services are offered on either a walk-in or appointment basis.

  • Clinic Hours
    8:00 a.m. - 4:30 p.m. (M, Tu, Th, F)
    8:00 a.m. - 6:30 p.m. (W)


Undetectable = Untransmittable (U=U)MDHHS supports Undetectable = Untransmittable HIV Prevention Campaign: MDHHS has joined the Centers for Disease Control and Prevention (CDC), the National Alliance of State and Territorial AIDS Directors (NASTAD), NAM, and other leaders in the fight to end the HIV epidemic by supporting the Prevention Access campaign Undetectable Equals Untransmittable (U=U).

Based on the emerging research, the scientific consensus is that a person living with HIV taking antiretroviral therapy (ART) as prescribed with an undetectable viral load in their blood sample for at least six months has a negligible risk of transmitting HIV sexually. Viral load refers to the amount of HIV in a blood sample of a person living with HIV. Most often, the higher the viral load, the greater the likelihood an individual with HIV will transmit HIV. ART must be taken daily to achieve viral suppression and maintain untransmittable status.



Return to HIV, STDs and Viral Hepatitis in Michigan home page